Contact Us

The choice depends on whether you are studying SRD5A1's role in steroid 5α-reductase activity or its contributions to androgen metabolism and dihydrotestosterone (DHT) synthesis. The Knockout line is appropriate for asking whether SRD5A1 (Type I) is required for testosterone-to-DHT conversion in non-prostate tissues — SRD5A1 has broader tissue expression than SRD5A2. Overexpression is useful for testing sufficiency or for studying inhibitor selectivity between SRD5A isoforms. For steroid metabolism research, the EDITGENE SRD5A1 Knockout in HAP1 provides a clean background, though SRD5A2 and SRD5A3 paralog expression should be assessed. Note that physiological androgen metabolism research often requires prostate or skin-derived cell models — HAP1 is most useful for biochemical and inhibitor specificity studies. Rescue with wild-type or catalytically-dead SRD5A1 enables structure-function dissection, particularly relevant for distinguishing finasteride and dutasteride selectivity.

Yes. SRD5A1 rescue experiments require attention to ER membrane targeting: • Construct design: use a codon-modified SRD5A1 sequence with a C-terminal tag (FLAG, HA). SRD5A1 is a multi-pass ER membrane protein — N-terminal tags can interfere with signal anchor function. • Catalytically-dead rescue: mutations in the conserved catalytic residues (typically targeting NADPH-binding or substrate-coordinating residues) abolish reductase activity and serve as enzymatic specificity controls. • Inhibitor-binding studies: rescue with wild-type SRD5A1 versus SRD5A2 enables direct comparison of finasteride and dutasteride selectivity in matched genetic backgrounds. • Functional readout: rescue should restore testosterone-to-DHT conversion measured by HPLC or LC-MS. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying SP3's role as a dual-function (activator/repressor) Sp/KLF family transcription factor or its specific contributions to GC-box-dependent gene expression. The Knockout line is appropriate for asking whether SP3 is required for GC-box-driven transcription in contexts where SP1 may not fully compensate. Overexpression is useful for studying SP3's repressive long isoform versus activating short isoform-specific effects. Important consideration: SP1 and SP3 share GC-box binding sites and have substantial functional overlap — single SP3 knockout in HAP1 may show mild phenotypes if SP1 compensates. The EDITGENE Knockout is most informative when SP1 status is assessed in parallel. Rescue with wild-type, DNA-binding-deficient, or isoform-specific (long vs short) SP3 enables comprehensive structure-function dissection.

Yes. SP3 rescue experiments require attention to isoform diversity and DNA-binding: • Construct design: use a codon-modified SP3 sequence with a C-terminal tag (FLAG, HA). SP3 has long (~115 kDa, repressive) and short (~78 kDa, activating) isoforms produced from alternative translation initiation. • Isoform-specific rescue: separate rescue with long versus short SP3 isoforms dissects their distinct transcriptional activities. • DNA-binding-deficient rescue: zinc finger mutations in the GC-box-binding region serve as the specificity control. • Paralog considerations: SP1 expression analysis interprets compensation effects in rescue experiments. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying SLC2A2 (GLUT2)'s role as the principal hepatic glucose transporter or modeling Fanconi-Bickel syndrome and diabetes-related glucose handling. The Knockout line is the standard tool for asking whether GLUT2 is required for bidirectional glucose transport — GLUT2 is the major glucose transporter in hepatocytes, pancreatic β-cells, and enterocytes, mediating both glucose uptake and release. Overexpression is useful for studying GLUT2 substrate selectivity (it transports glucose, fructose, galactose, and glucosamine). For hepatic glucose research, the EDITGENE GLUT2 Knockout in Huh-7 is highly relevant — Huh-7 has hepatocellular origin and supports physiologically meaningful glucose transport studies. SLC2A2 mutations cause Fanconi-Bickel syndrome (hepatomegaly, renal Fanconi syndrome, glucose intolerance) — disease variant rescue enables genotype-function correlation studies. Rescue with wild-type or transport-deficient GLUT2 is the standard specificity control.

Yes. GLUT2 rescue experiments are well-established in hepatic glucose biology: • Construct design: use a codon-modified SLC2A2 sequence with a small C-terminal tag (FLAG, HA). GLUT2 has 12 transmembrane domains — preserve plasma membrane targeting determinants. • Surface localization validation: confirm plasma membrane localization by cell surface biotinylation before glucose transport assays. • Disease mutation rescue: Fanconi-Bickel syndrome-associated SLC2A2 mutations enable genotype-function studies. • Functional readout: rescue should restore glucose, fructose, and galactose transport activities measured by radiolabel or LC-MS uptake assays. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation in a hepatocyte-derived background appropriate for GLUT2 functional studies.

The choice depends on whether you are studying SUMO3's role in stress-inducible SUMOylation or its distinct functions from SUMO1 and SUMO2. The Knockout line is appropriate for asking whether SUMO3-specific SUMOylation is required for stress responses, given that SUMO3 (with SUMO2) forms polySUMO chains, distinct from SUMO1's monoSUMOylation behavior. Overexpression is useful for studying chain length effects or substrate selectivity differences. Important consideration: SUMO2 and SUMO3 are ~97% identical at the amino acid level and form indistinguishable polySUMO chains — single SUMO3 knockout phenotypes are typically mild because SUMO2 substitutes effectively. The EDITGENE Knockout in HAP1 is most informative when SUMO2 status is also characterized. Rescue with wild-type SUMO3 or with chain-formation-deficient variants (K11R) enables polySUMO chain studies.

Yes. SUMO3 rescue experiments require attention to chain formation and paralog redundancy: • Construct design: use a codon-modified SUMO3 sequence with a small N-terminal tag (HA, FLAG); C-terminal tagging interferes with the diglycine motif required for conjugation. Note that the mature SUMO3 protein lacks the C-terminal residues following the GG diglycine. • Chain-formation-deficient rescue: the K11R mutation prevents polySUMO chain formation, enabling discrimination of mono- versus poly-SUMOylation effects. • SUMO2 paralog considerations: SUMO3 rescue interpretation requires SUMO2 status assessment given their ~97% identity and indistinguishable polySUMO chain formation. • Functional readout: rescue should restore SUMOylation patterns of SUMO3-preferential substrates and stress-inducible SUMOylation under heat shock or proteotoxic challenges. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying SLC5A12 (SMCT2)'s role in low-affinity sodium-coupled monocarboxylate transport or its specific functions in kidney and intestinal lactate/butyrate uptake. The Knockout line is appropriate for asking whether SMCT2 is required for these transport activities — SMCT2 (along with SMCT1/SLC5A8) handles sodium-dependent monocarboxylate uptake. Overexpression is useful for transport activity assays and substrate scope characterization. For monocarboxylate transport research, the EDITGENE SLC5A12 Knockout in Huh-7 is relevant for hepatic monocarboxylate handling studies — though SMCT2 is principally expressed in kidney and intestine. SMCT1 expression analysis aids interpretation of SMCT2-specific functions given paralog overlap. Rescue with wild-type or transport-deficient SMCT2 enables structure-function studies.

Yes. SMCT2 rescue experiments require attention to sodium-coupled transport mechanism: • Construct design: use a codon-modified SLC5A12 sequence with a small C-terminal tag (FLAG, HA). The 13 transmembrane SLC5 architecture must be preserved. • Transport-deficient rescue: sodium-binding or substrate-binding mutations enable mechanistic studies. • Functional readout: rescue should restore sodium-dependent monocarboxylate uptake (³H-lactate, ³H-butyrate). • Paralog discrimination: comparison of rescue effects with parallel SMCT1 expression characterizes SMCT2-specific functions. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC30A10 (ZnT10)'s role in manganese efflux or modeling parkinsonism with hypermanganesemia. The Knockout line is the standard tool for asking whether SLC30A10 is required for cellular manganese extrusion — despite its SLC30 'zinc transporter' family designation, SLC30A10 is the principal cellular manganese efflux transporter, distinct from other ZnT family members. Overexpression is useful for testing manganese transport activity in heterologous systems and for rescue with disease-associated mutations. For manganese biology research, the EDITGENE SLC30A10 Knockout in Huh-7 is highly relevant — hepatic SLC30A10 mediates biliary manganese excretion, and its loss-of-function causes hepatic cirrhosis, dystonia, parkinsonism, and polycythemia (HMNDYT1, hypermanganesemia with dystonia type 1). Rescue with wild-type, transport-deficient, or patient-derived mutant SLC30A10 enables comprehensive disease modeling. This product is particularly valuable for manganese-related neurodegenerative disease research.

Yes. SLC30A10 rescue experiments are well-established for manganese biology research: • Construct design: use a codon-modified SLC30A10 sequence with a small C-terminal tag (FLAG, HA). The 6 transmembrane ZnT family architecture must be preserved. • Disease mutation rescue: HMNDYT1-associated patient mutations (L89P, T196P, frameshift mutations) enable comprehensive disease genotype-function studies. • Surface localization validation: confirm plasma membrane localization by cell surface biotinylation — many disease mutations cause trafficking defects. • Functional readout: rescue should restore cellular manganese efflux measured by ICP-MS or Mn²⁺ fluorescent probes following manganese loading. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation in a hepatocyte-derived background appropriate for biliary Mn²⁺ excretion studies.

The choice depends on whether you are studying SLC6A12 (BGT-1)'s role in betaine/GABA transport or its emerging functions in osmotic regulation and hepatic biology. The Knockout line is appropriate for asking whether BGT-1 is required for betaine uptake — particularly relevant in hepatocyte-derived contexts where betaine is critical for methylation reactions and osmotic protection. Overexpression is useful for transport kinetics studies and for assessing BGT-1 in hyperosmolar adaptation. For betaine/GABA transport research, the EDITGENE SLC6A12 Knockout in Huh-7 is particularly relevant for hepatic methionine cycle and one-carbon metabolism studies — betaine is a major methyl donor in liver. Rescue with wild-type or transport-deficient BGT-1 enables structure-function studies, and is a specificity control for BGT-1 inhibitors (some anticonvulsants like EF1502).

Yes. BGT-1 rescue experiments require attention to substrate specificity: • Construct design: use a codon-modified SLC6A12 sequence with a small C-terminal tag (FLAG, HA). The 12 transmembrane SLC6 architecture must be preserved. • Transport-deficient rescue: substrate-binding mutations enable distinguishing betaine from GABA transport activities. • Functional readout: rescue should restore ³H-betaine and ³H-GABA uptake activities; hepatic methionine cycle metabolite analysis assesses downstream metabolic consequences. • BGT-1 inhibitor selectivity: rescue with wild-type BGT-1 enables specificity testing of anticonvulsants targeting this transporter. Huh-7 transduces efficiently with lentivirus and supports hepatocyte-relevant rescue line studies.

The choice depends on whether you are studying SLCO1A2 (OATP1A2)'s role in drug uptake at the blood-brain barrier and intestine or its contributions to drug pharmacokinetics. The Knockout line is the standard tool for asking whether SLCO1A2 is required for cellular uptake of its substrates — including thyroid hormones, BSP, and many drugs subject to OATP1A2-mediated transport. Overexpression is useful for transport kinetics studies and inhibitor specificity testing. For pharmacokinetics research, the EDITGENE SLCO1A2 Knockout in Huh-7 provides a hepatocyte-derived background for studying transport biology, though SLCO1A2's principal physiological sites are intestine and brain endothelium rather than liver. The model is particularly useful for drug-drug interaction studies and OATP1A2 inhibitor characterization. Rescue with wild-type or transport-deficient SLCO1A2 enables mechanism and selectivity studies.